| A randomized, placebo‐controlled trial of infliximab plus methotrexate for the treatment of polyarticular‐course juvenile rheumatoid arthritis N Ruperto, DJ Lovell, R Cuttica, N Wilkinson, P Woo, G Espada, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2007 | 491 | 2007 |
| The complement regulator factor H binds to the surface protein OspE of Borrelia burgdorferi J Hellwage, T Meri, T Heikkilä, A Alitalo, J Panelius, P Lahdenne, ... Journal of Biological Chemistry 276 (11), 8427-8435, 2001 | 469 | 2001 |
| Leflunomide or methotrexate for juvenile rheumatoid arthritis E Silverman, R Mouy, L Spiegel, LK Jung, RK Saurenmann, P Lahdenne, ... New England journal of medicine 352 (16), 1655-1666, 2005 | 356 | 2005 |
| Incidence of juvenile idiopathic arthritis in the Nordic countries. A population based study with special reference to the validity of the ILAR and EULAR criteria. L Berntson, BA Gäre, A Fasth, T Herlin, J Kristinsson, P Lahdenne, ... The Journal of rheumatology 30 (10), 2275-2282, 2003 | 339 | 2003 |
| Treating juvenile idiopathic arthritis to target: recommendations of an international task force A Ravelli, A Consolaro, G Horneff, RM Laxer, DJ Lovell, NM Wulffraat, ... Annals of the rheumatic diseases 77 (6), 819-828, 2018 | 310 | 2018 |
| Campylobacter‐triggered reactive arthritis: a population‐based study T Hannu, L Mattila, H Rautelin, P Pelkonen, P Lahdenne, A Siitonen, ... Rheumatology 41 (3), 312-318, 2002 | 285 | 2002 |
| Infliximab or etanercept in the treatment of children with refractory juvenile idiopathic arthritis: an open label study P Lahdenne, P Vähäsalo, V Honkanen Annals of the rheumatic diseases 62 (3), 245-247, 2003 | 284 | 2003 |
| Adalimumab in juvenile idiopathic arthritis-associated chronic anterior uveitis P Tynjälä, K Kotaniemi, P Lindahl, K Latva, K Aalto, V Honkanen, ... Rheumatology 47 (3), 339-344, 2008 | 272 | 2008 |
| Infliximab and etanercept in the treatment of chronic uveitis associated with refractory juvenile idiopathic arthritis P Tynjälä, P Lindahl, V Honkanen, P Lahdenne, K Kotaniemi Annals of the rheumatic diseases 66 (4), 548-550, 2007 | 272 | 2007 |
| Ongoing disease activity and changing categories in a long‐term nordic cohort study of juvenile idiopathic arthritis E Nordal, M Zak, K Aalto, L Berntson, A Fasth, T Herlin, P Lahdenne, ... Arthritis & Rheumatism 63 (9), 2809-2818, 2011 | 269 | 2011 |
| Consensus-based recommendations for the management of juvenile dermatomyositis FB Enders, B Bader-Meunier, E Baildam, T Constantin, P Dolezalova, ... Annals of the rheumatic diseases 76 (2), 329-340, 2017 | 257 | 2017 |
| Aggressive combination drug therapy in very early polyarticular juvenile idiopathic arthritis (ACUTE–JIA): a multicentre randomised open-label clinical trial P Tynjälä, P Vähäsalo, M Tarkiainen, L Kröger, K Aalto, M Malin, ... Annals of the rheumatic diseases 70 (9), 1605-1612, 2011 | 253 | 2011 |
| European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis—the SHARE initiative S Ozen, SD Marks, P Brogan, N Groot, N de Graeff, T Avcin, ... Rheumatology 58 (9), 1607-1616, 2019 | 244 | 2019 |
| Complement inhibitor factor H binding to Lyme disease spirochetes is mediated by inducible expression of multiple plasmid-encoded outer surface protein E paralogs A Alitalo, T Meri, H Lankinen, I Seppälä, P Lahdenne, PS Hefty, ... The Journal of Immunology 169 (7), 3847-3853, 2002 | 211 | 2002 |
| European evidence-based recommendations for diagnosis and treatment of childhood-onset systemic lupus erythematosus: the SHARE initiative N Groot, N De Graeff, T Avcin, B Bader-Meunier, P Brogan, P Dolezalova, ... Annals of the rheumatic diseases 76 (11), 1788-1796, 2017 | 191 | 2017 |
| Proxy‐reported health‐related quality of life of patients with juvenile idiopathic arthritis: the Pediatric Rheumatology International Trials Organization multinational quality … S Oliveira, A Ravelli, A Pistorio, E Castell, C Malattia, AM Prieur, ... Arthritis Care & Research: Official Journal of the American College of …, 2007 | 171 | 2007 |
| European consensus-based recommendations for the diagnosis and treatment of Kawasaki disease–the SHARE initiative N de Graeff, N Groot, S Ozen, D Eleftheriou, T Avcin, B Bader-Meunier, ... Rheumatology 58 (4), 672-682, 2019 | 168 | 2019 |
| Decorin-Binding Protein of Borrelia burgdorferi Is Encoded within a Two-Gene Operon and Is Protective in the Murine Model of Lyme Borreliosis KE Hagman, P Lahdenne, TG Popova, SF Porcella, DR Akins, JD Radolf, ... Infection and immunity 66 (6), 2674-2683, 1998 | 156 | 1998 |
| Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort study A Consolaro, G Giancane, A Alongi, EHP van Dijkhuizen, A Aggarwal, ... The Lancet Child & Adolescent Health 3 (4), 255-263, 2019 | 149 | 2019 |
| European evidence-based recommendations for the diagnosis and treatment of childhood-onset lupus nephritis: the SHARE initiative N Groot, N De Graeff, SD Marks, P Brogan, T Avcin, B Bader-Meunier, ... Annals of the rheumatic diseases 76 (12), 1965-1973, 2017 | 139 | 2017 |
